ORIC Pharmaceuticals, Inc.
ORIC
$10.85
$0.201.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.25% | 5.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.13% | 19.40% | |||
| Operating Income | 6.13% | -19.40% | |||
| Income Before Tax | 10.36% | -21.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.36% | -21.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.36% | -21.10% | |||
| EBIT | 6.13% | -19.40% | |||
| EBITDA | 6.12% | -19.55% | |||
| EPS Basic | 29.23% | -10.10% | |||
| Normalized Basic EPS | 29.23% | -10.11% | |||
| EPS Diluted | 29.23% | -10.10% | |||
| Normalized Diluted EPS | 29.23% | -10.11% | |||
| Average Basic Shares Outstanding | 26.66% | 9.97% | |||
| Average Diluted Shares Outstanding | 26.66% | 9.97% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||